Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Memory Enhancement in Aging With Optimal Dosing

NCT: NCT07461584 · NOT_YET_RECRUITING

NCT IDNCT07461584
StatusNOT_YET_RECRUITING
Start Date2026-05-01
Completion2031-01-31

Brief Summary

This project optimizes high-resolution tACS to improve memory in healthy older adults, advancing drug-free approaches for ADRD. We test stimulation schedules and develop an adaptive, brain-guided tACS system to strengthen memory-supporting networks.

Frequently Asked Questions

What is Memory Enhancement in Aging With Optimal Dosing?

Memory Enhancement in Aging With Optimal Dosing is a clinical trial registered under NCT07461584. Current status: NOT_YET_RECRUITING.

What is the status of NCT07461584?

The current status of NCT07461584 (Memory Enhancement in Aging With Optimal Dosing) is: NOT_YET_RECRUITING.

When did Memory Enhancement in Aging With Optimal Dosing start?

Memory Enhancement in Aging With Optimal Dosing started on 2026-05-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.